Translation of "Leberentzündung" in English

Some patients have developed liver inflammation after receiving LEMTRADA.

It means protection against plague carnivorous, and also infectious hepatitis.

Hepatitis A and E (which cause inflammation of the liver),

Gummatous hepatitis may be symptomatic and lead to eventual cirrhosis.

Hepatitis E - It is a contagious disease, acute inflammation of the liver.

This would inflame the liver.

Contraindications Hypersensitivity, hepatitis and cirrhosis combined with severe liver failure.

At the started condition leads to a chronic hepatitis and a cirrhosis.

On the other hand, hepatitis B, C and D can cause chronic liver infection.

An ultrasound examination or a liver biopsy can reveal the extent of the liver inflammation.

Hepatitis viruses cause hepatitis (liver inflammation).

It gives protections against both (A and B) types of hepatitis.

Chronic liver inflammation also increases the risk of liver cancer.

Autoimmune hepatitis can be acute, with signs of liver inflammation.

Emilie died on 12 February 1843 in Frankfurt am Main to a liver infection and was buried at the Main Cemetery in Frankfurt.

Rare - may affect up to 1 in 1000 people - disorder of the liver (hepatitis).

Hepatitis is an inflammation of the liver.

Thus, liver inflammation, fibrosis and cirrhosis are the most important contributors to HCC development and progression.

Alcohol damages the liver cells and leads to chronic liver inflammation over time.

It aims to call attention to chronic liver inflammation caused by viruses, the causes of its induction and the significance of early recognition.

This enhancement in efficacy included loss of serum HCV (< 100 copies/ ml by PCR), improvement in hepatic inflammation, and normalisation of ALT, and was sustained when rod

Serious allergic reactions (including severe localised swelling of the skin and wheezing); lymphoma (a type of blood cancer); leukaemia (cancer affecting the blood and bone marrow); melanoma (a type of skin cancer); combined low platelet, red, and white blood cell count; nervous system disorders (with severe muscle weakness and signs and symptoms similar to those of multiple sclerosis or inflammation of the nerves of the eyes or spinal cord); tuberculosis; new onset congestive heart failure; seizures; lupus or lupus-like syndrome (symptoms may include persistent rash, fever, joint pain, and tiredness); skin rash, which may lead to severe blistering and peeling of the skin; lichenoid reactions (itchy reddish-purple skin rash and/or threadlike white-grey lines on mucous membranes); inflammation of the liver caused by the body's own immune system (autoimmune hepatitis; in patients also receiving methotrexate treatment, the frequency is uncommon); immune disorder that can affect the lungs, skin and lymph nodes (sarcoidosis); inflammation or scarring of the lungs (in patients also receiving methotrexate treatment, the frequency of inflammation or scarring of the lungs is uncommon).

Although ALT elevations associated with dasabuvir and ombitasvir/paritaprevir/ritonavir have been asymptomatic, patients should be instructed to watch for early warning signs of liver inflammation, such as fatigue, weakness, lack of appetite, nausea and vomiting, as well as later signs such as jaundice and discoloured faeces, and to consult a doctor without delay if such symptoms occur.

Although ALT elevations associated with Viekirax and dasabuvir have been asymptomatic, patients should be instructed to watch for early warning signs of liver inflammation, such as fatigue, weakness, lack of appetite, nausea and vomiting, as well as later signs such as jaundice and discoloured faeces, and to consult a doctor without delay if such symptoms occur.

The most common side effects with Cimzia (affecting up to 1 in 10 people) are bacterial infections including abscesses (a swollen area where pus has collected), viral infections (including herpes, papillomavirus and influenza), eosinophilic disorders (disorders of eosinophils, a type of white blood cell), leucopenia (low white blood cell counts), nausea (feeling sick), headaches (including migraine), sensory abnormalities (such as numbness, tingling and burning sensation), high blood pressure, hepatitis (liver inflammation) including increased levels of liver enzymes, rash, fever, pain, weakness, itching and reactions at the injection site.

Influenza, respiratory infections, poor appetite or loss of appetite, dizziness, convulsions (fits), irregular or slow heart rate, cough, vomiting, abdominal pain, diarrhoea, nausea, inflammation or enlargement of the liver, abnormal liver function tests, itching, pain in the muscles or joints.